CARR EDWARD — SEC insider filings
SEC reporting owner CIK 1273351. 12 insider filings on record with FilingPulse; latest filed 2026-09-18.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2020-10-13 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 4 filings — 148,249 shares, $5,718,448 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: sale of 23,465 shares @ $81.75 ($1,918,264) in Dianthus Therapeutics, Inc. /DE/, filed 2026-03-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | 6 | — | 10 legs · 63,682 sh · $5,587,140 | 12 |
| ABEONA THERAPEUTICS INC. (ABEO) | Chief Financial Officer | 6 | — | 3 legs · 84,567 sh · $131,308 | 13 |
Insider filings — CARR EDWARD
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 20,000 @ $17.88 · Sale (S): 7,928 @ $100.43 · Sale (S): 6,771 @ $101.37 · Sale (S): 3,501 @ $102.39 · Sale (S): 1,100 @ $103.20 · Sale (S): 700 @ $104.39 · +1 more | EDGAR |
| 2026-03-13 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 16,182 @ $17.88 · Option exercise (M): 17,500 @ $22.07 · Option exercise (M): 10,000 @ $21.77 · Sale (S): 15,852 @ $80.71 · Sale (S): 23,465 @ $81.75 · Sale (S): 3,865 @ $82.66 · +5 more | EDGAR |
| 2026-02-04 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-01-26 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2021-10-08 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Sale (S): 29,122 @ $1.05 | EDGAR |
| 2021-08-12 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Grant/award (A): 238,000 @ $0 · Grant/award (A): 476,000 (derivative) @ $0 | EDGAR |
| 2021-04-05 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Sale (S): 20,445 @ $1.85 · Sale (S): 35,000 @ $1.80 | EDGAR |
| 2021-03-03 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2020-11-20 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Grant/award (A): 28,919 (derivative) · Disposition to issuer (D): 28,919 (derivative) · Grant/award (A): 51,081 (derivative) · Disposition to issuer (D): 51,081 (derivative) · Grant/award (A): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +2 more | EDGAR |
| 2020-10-13 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Grant/award (A): 143,182 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-13 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1273351 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs